Page last updated: 2024-11-01

ondansetron and Kidney Diseases

ondansetron has been researched along with Kidney Diseases in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"Heptaplatin is a newly developed platinum derivative which has been reported to be less toxic than cisplatin."2.70Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. ( Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, JH1
Kang, YK1
Kim, TW1
Bahng, H1
Chang, HM1
Kang, WC1
Kim, WK1
Lee, JS1
Park, JS1
Gallegos-Castorena, S1
Martínez-Avalos, A1
Mohar-Betancourt, A1
Guerrero-Avendaño, G1
Zapata-Tarrés, M1
Medina-Sansón, A1

Trials

2 trials available for ondansetron and Kidney Diseases

ArticleYear
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

    Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protoc

2002
Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
    Pediatric hematology and oncology, 2007, Volume: 24, Issue:6

    Topics: Adolescent; Amifostine; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms;

2007